ArticleThe Journal of clinical investigation2026

EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ.

Wei-Tao Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.